Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Neurocrine Biosciences Inc (NBIX) vs Nuscale Power Corporation (SMR) Price & Performance

Neurocrine Biosciences IncTrade
Nuscale Power CorporationTrade

Price performance (Past 24H)

Key statistics

Neurocrine Biosciences Inc vs Nuscale Power Corporation — how do they compare? Neurocrine Biosciences Inc trades at $179.88 (market cap $17.40B), while Nuscale Power Corporation trades at $8.81 (market cap $2.76B). The key difference: Neurocrine Biosciences Inc is far larger — about 6.3× Nuscale Power Corporation's market cap, and Neurocrine Biosciences Inc is trading nearer its 52-week high, Nuscale Power Corporation nearer its low. Which is the better fit depends on your goals.

NBIXSMR
Market Cap
$17.40B$2.76B
Sector
HealthUtilities
52-Week High
$180.55$53.43
52-Week Low
$123.10$7.64
Enterprise Value
$16.49B$1.87B

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Neurocrine Biosciences Inc

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on discovering, developing, and commercializing innovative treatments for neurological, endocrine, and psychiatric disorders. The company's portfolio targets conditions such as tardive dyskinesia, endometriosis, and Parkinson's disease. NBIX leverages its expertise in neurobiology and small-molecule drug development to address diseases with significant unmet medical needs.

Read more on NBIX

About Nuscale Power Corporation

NuScale Power Corporation is a leading developer of Small Modular Reactor (SMR) technology. The company's flagship product is a light water reactor SMR designed to generate clean, reliable, and scalable nuclear power. NuScale's technology is poised to address the global demand for carbon-free energy by offering a safer, smaller, and more flexible alternative to traditional large-scale nuclear power plants, with applications in electricity generation, desalination, and process heat.

Read more on SMR